Grey
Brand Name(s):Avastin
Indication:Renal cell cancer (Advanced and/or Metastatic), Metastatic cancer of colon or rectum
Rationale:1
Considered:Jan-08
Review Date:Oct-25
Comments:
NICE TA 242
NICE unable to recommend for use
Details available at:https://www.nice.org.uk/guidance/ta242
Jan 2012